Evidence map›Paper›PMID 39911789›Full record

ArticleFrontiers in public health2024

Management of rare and undiagnosed diseases: insights from researchers and healthcare professionals in Türkiye.

Sinem Durmus, Emrah Yucesan, Sinem Aktug, Begum Utz, Ahmet Okay Caglayan, Pinar Gencpinar, Cagatay Günay, Yavuz Oktay, Ravza Nur Yildirim, Ayca Yigit and 1 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sinem DurmusDepartment of Medical Biochemistry, Faculty of Medicine, İzmir Katip Çelebi University, Izmir, Türkiye.
Emrah YucesanInstitute of Neurological Sciences Department of Neurogenetics, Istanbul University-Cerrahpasa, Istanbul, Türkiye.
Sinem AktugIzmir Biomedicine and Genome Center, Izmir, Türkiye.
Begum UtzIzmir Biomedicine and Genome Center, Izmir, Türkiye.
Ahmet Okay CaglayanIzmir Biomedicine and Genome Center, Izmir, Türkiye.
Pinar GencpinarDepartment of Pediatric Neurology, Faculty of Medicine, Izmir Katip Celebi University, Izmir, Türkiye.
Cagatay GünayDepartment of Pediatric Neurology, Faculty of Medicine, Dokuz Eylül University, Izmir, Türkiye.
Yavuz OktayIzmir Biomedicine and Genome Center, Izmir, Türkiye.
Ravza Nur YildirimIzmir Biomedicine and Genome Center, Izmir, Türkiye.
Ayca YigitIzmir Biomedicine and Genome Center, Izmir, Türkiye.
Ugur OzbekIzmir Biomedicine and Genome Center, Izmir, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Diagnosis, treatment and management of rare diseases (RD) pose unique challenges due to their complex nature, significantly impacting the daily experiences of researchers and healthcare professionals working in this field. Despite increasing awareness and progress in the field of RD worldwide in recent years, a significant gap remains in our understanding of the specific barriers that these professionals face in their work with RD. This study provides a detailed survey analysis that sheds light on the challenges that researchers and healthcare professionals face in diagnosing, treating, managing and conducting research on RD. Methods: We developed a national online survey with three RD stakeholder groups (Researchers, Healthcare professionals and researcher-healthcare professionals) to identify the main challenges and needs in Türkiye for the diagnosis, treatment and follow-up processes of rare and undiagnosed diseases. Results: The survey was completed by 363 participants, revealing that participants face key challenges such as the need to refer patients to specialized centers, financial burdens, limited access to necessary tests, inadequate support for rare disease research and a lack of interdisciplinary collaboration. Participants also noted that RD are inherently difficult to conduct research on with small cohorts. Survey results also suggest a number of policy improvements to accelerate research on RD: increased funding, establishment of robust surveillance systems, and development of comprehensive national action plans and guidelines on RD. Discussion: To the best of our knowledge, this is the first study to be conducted in Türkiye. This study contributes to the understanding of the needs of professionals in rare disease research and highlights the urgent need for system improvements to support them.

Indexed as

Health PersonnelRare DiseasesResearch PersonnelUndiagnosed DiseasesAdultFemaleHumansMaleMiddle AgedSurveys and QuestionnairesRareBoostrare diseasesurveyTürkiyeundiagnosed diseaseunmet needs

Identifiers

PMID39911789
PMCPMC11795313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.